Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
NYSE:CRL
Price:
214.51 USD
-0.13%
Market Closed
Updated:
Jun 11, 2024
Charles River Laboratories International Inc
Long-Term Debt
|
Charles River Laboratories International Inc
Long-Term Debt Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Charles River Laboratories International Inc
NYSE:CRL
|
Long-Term Debt
$2.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Long-Term Debt
$31.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Danaher Corp
NYSE:DHR
|
Long-Term Debt
$16.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Long-Term Debt
$1.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Long-Term Debt
$2.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Long-Term Debt
$12.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is Charles River Laboratories International Inc's Long-Term Debt?
Long-Term Debt
2.7B
USD
2.7B
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Long-Term Debt amounts to 2.7B USD.
What is Charles River Laboratories International Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
16%
16%
Over the last year, the Long-Term Debt growth was -3%. The average annual Long-Term Debt growth rates for Charles River Laboratories International Inc have been 7% over the past three years , 12% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
